Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles.

Fujita J.

Circ J. 2013;77(1):35-40. Epub 2012 Dec 12. Review.

2.

Report of the American Heart Association (AHA) Scientific Sessions 2013, Dallas.

Ishimori N, Kinugawa S, Yamada S, Yokoshiki H, Mitsuyama H, Tsutsui H.

Circ J. 2014;78(1):51-6. Epub 2013 Dec 13.

3.

Report of the American Heart Association (AHA) Scientific Sessions 2014, Chicago.

Kohno T.

Circ J. 2015;79(1):34-40. doi: 10.1253/circj.CJ-14-1329. Epub 2014 Dec 15.

4.

Conference report from the 2012 AHA scientific sessions in Los Angeles.

Westenbrink BD, Edwards AG, Miyamoto S.

Expert Opin Ther Targets. 2013 Jun;17(6):733-7. doi: 10.1517/14728222.2013.794791. Epub 2013 May 4.

PMID:
23642039
6.

Report of the American Heart Association (AHA) Scientific Sessions 2015, Orlando.

Aizawa Y, Kimura M, Kohno T, Fujita J, Fukuda K.

Circ J. 2016;80(1):51-7. doi: 10.1253/circj.CJ-15-1272. Epub 2015 Dec 11.

7.

Give me FREEDOM or...

King SB 3rd.

JACC Cardiovasc Interv. 2012 Nov;5(11):1190-1. doi: 10.1016/j.jcin.2012.10.002. No abstract available.

8.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
9.

[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].

Silber S, Richartz BM, Brilmayer M; European Society of Cardiology (ESC).

Herz. 2006 Dec;31(9):836-46, 848. German.

PMID:
17180646
10.

Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?

Chieffo A, Colombo A.

Nat Clin Pract Cardiovasc Med. 2005 Aug;2(8):396-400. Review.

PMID:
16119701
11.

Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.

Stone GW, Kedhi E, Kereiakes DJ, Parise H, Fahy M, Serruys PW, Smits PC.

Circulation. 2011 Aug 23;124(8):893-900. doi: 10.1161/CIRCULATIONAHA.111.031070. Epub 2011 Aug 8.

13.

Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.

Celik T, Iyisoy A, Yuksel UC, Isik E.

Int J Cardiol. 2009 Jan 9;131(2):269-70; author reply 271-2. Epub 2007 Aug 10.

PMID:
17692947
14.

Multivessel percutaneous coronary intervention: a new paradigm for a new century.

Morrison DA.

Minerva Cardioangiol. 2005 Oct;53(5):361-77. Review.

PMID:
16179881
15.

Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s.

Zaacks SM, Allen JE, Calvin JE, Schaer GL, Palvas BW, Parrillo JE, Klein LW.

Am J Cardiol. 1998 Jul 1;82(1):43-9.

PMID:
9671007
16.

One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.

Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A.

J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601.

PMID:
17667030
17.

For which patients with left main stem disease is percutaneous intervention rather than coronary artery bypass grafting the better option?

Malvindi PG, Dunning J, Vitale N.

Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):306-14. doi: 10.1510/icvts.2007.169938. Epub 2008 Jan 14. Review.

PMID:
18194978
18.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.

Lee MS, Park KW, Kang SH, Sheiban I, Mahmud E, Thani KB, Cheng R, Cho JH, Jin DK, Gwon HC, Chae IH, Aragon J, Gillis K, Stone GW, Kim HS.

J Invasive Cardiol. 2012 Jul;24(7):316-9.

19.

Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials.

Vasaiwala S, Williams DO.

Curr Cardiol Rep. 2012 Aug;14(4):468-76. doi: 10.1007/s11886-012-0274-x. Review.

PMID:
22638907
20.

[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].

Silber S, Herdeg C.

Herz. 2008 Apr;33(3):196-205. doi: 10.1007/s00059-008-3121-5. Review. German.

PMID:
18568314

Supplemental Content

Support Center